Login
$MREO
$0.30 -$0.00 (0.85%) After hours

Company Executives

Officer Age In this role Source
Denise Scots-Knight Also a director
Chief Executive Officer and Director
66 Not stated
Christine Fox
Chief Financial Officer
45 Since 2021
5 years
John Lewicki
Chief Scientific Officer
74 Since 2020
6 years
Charles Sermon
General Counsel and Business Development
56 Not stated
Alexandra (Wills) Hughes-Wilson
Chief Patient Access and Commercial Planning
54 Since 2018
8 years

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
10
serving now
Average tenure
7.0 years
from year joined
Director On board Committees Other public boards 2025 pay Source
Denise Scots-Knight
Not stated None stated Elanco Animal Health Incorporated Paid as CEO
Justin Roberts
Not stated
Remuneration Committee
None stated Not stated
Daniel Shames
Not stated None stated None stated Not stated
Marc Yoskowitz
Not stated None stated None stated $181,167
Michael Wyzga
2019
7 years
Nomination and Corporate Governance Committee · Chair
GenSight Biologics S.A. $234,154
Jeremy Bender
Not stated None stated None stated Not stated
Anders Ekblom
Not stated None stated Xspray Pharma AB Not stated
Pierre Jacquet
Not stated None stated Neurvati Not stated
Deepika Pakianathan
Not stated None stated Theravance Biopharma, Inc., Karyopharm Therapeutics, Inc. Not stated
Annalisa Jenkins Leaving at the meeting
Not stated None stated Compass Pathways plc, Skye Bioscience, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 9, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support